These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1965104

  • 21. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
    Fong IW, Bannatyne RM, Wong P.
    Genitourin Med; 1993 Feb; 69(1):44-6. PubMed ID: 8383096
    [Abstract] [Full Text] [Related]

  • 22. Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.
    Velegraki A, Papalambrou D, Soremi S, Legakis NJ.
    Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):854-60. PubMed ID: 8997556
    [Abstract] [Full Text] [Related]

  • 23. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK, Kohli Y.
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [Abstract] [Full Text] [Related]

  • 24. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [Abstract] [Full Text] [Related]

  • 25. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    Nguyen MH, Yu CY.
    J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
    [Abstract] [Full Text] [Related]

  • 26. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW, Meynaar I, Linde I, Poell R, Mattie H, Van Furth R.
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [Abstract] [Full Text] [Related]

  • 27. Effect of antifungal agents on the adherence of Candida albicans to murine gastrointestinal mucosal surfaces.
    Mehentee JF, Hay RJ.
    J Antimicrob Chemother; 1990 Jan; 25(1):111-9. PubMed ID: 2156790
    [Abstract] [Full Text] [Related]

  • 28. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
    Hughes CE, Bennett RL, Tuna IC, Beggs WH.
    Antimicrob Agents Chemother; 1988 Feb; 32(2):209-12. PubMed ID: 2834995
    [Abstract] [Full Text] [Related]

  • 29. High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    Darma S, Ambara A, Aman AT, Annisa L, Nurrokhman, Nuryastuti T, Wibawa T.
    PLoS One; 2020 Feb; 15(11):e0242542. PubMed ID: 33212470
    [Abstract] [Full Text] [Related]

  • 30. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
    Ponce E, Pechère JC.
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
    [Abstract] [Full Text] [Related]

  • 31. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
    Arias A, Arévalo MP, Andreu A, Rodríguez C, Sierra A.
    Mycoses; 1994 Oct; 37(7-8):285-9. PubMed ID: 7739661
    [Abstract] [Full Text] [Related]

  • 32. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G.
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [Abstract] [Full Text] [Related]

  • 33. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L.
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [Abstract] [Full Text] [Related]

  • 34. [In vitro effect of itraconazole against various species of Candida].
    Bastide M, Mallie M, Jouvert S, Montes B, Bastide JM.
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
    [Abstract] [Full Text] [Related]

  • 35. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
    Yang HC, Mikami Y, Yazawa K, Taguchi H, Nishimura K, Miyaji M, Branchini ML, Aoki FH, Yamamoto K.
    Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
    [Abstract] [Full Text] [Related]

  • 36. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
    Milan EP, Burattini MN, Kallás EG, Fischmann O, Costa PR, Colombo AL.
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):211-6. PubMed ID: 9884838
    [Abstract] [Full Text] [Related]

  • 37. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363.
    Lamb DC, Kelly DE, Manning NJ, Kelly SL.
    FEMS Microbiol Lett; 1997 Feb 15; 147(2):189-93. PubMed ID: 9119192
    [Abstract] [Full Text] [Related]

  • 38. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
    Bueno MG, Urban VM, Barbério GS, da Silva WJ, Porto VC, Pinto L, Neppelenbroek KH.
    Oral Dis; 2015 Jan 15; 21(1):57-65. PubMed ID: 24219354
    [Abstract] [Full Text] [Related]

  • 39. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
    Le Guennec R, Reynes J, Mallié M, Pujol C, Janbon F, Bastide JM.
    J Clin Microbiol; 1995 Oct 15; 33(10):2732-7. PubMed ID: 8567915
    [Abstract] [Full Text] [Related]

  • 40. [Effect of itraconazole on the process of mycelial transformation of Candida albicans cells in human serum].
    Gwiezdziński Z, Urbanowski S, Nierebińska E.
    Med Dosw Mikrobiol; 1989 Oct 15; 41(3-4):202-5. PubMed ID: 2561811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.